Evidence map›Paper›PMID 29304079›Full record

ArticlePloS one2018

Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency.

Takeshi Okada, Tohru Ohama, Mitsuyo Okazaki, Kotaro Kanno, Hibiki Matsuda, Masami Sairyo, Yinghong Zhu, Ayami Saga, Takuya Kobayashi, Daisaku Masuda and 4 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Takeshi OkadaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Tohru OhamaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Mitsuyo OkazakiTokyo Medical and Dental University, Tokyo, Japan.
Kotaro KannoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Hibiki MatsudaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Masami SairyoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Yinghong ZhuDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Ayami SagaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Takuya KobayashiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Daisaku MasudaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Masahiro KosekiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Makoto NishidaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Yasushi SakataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Shizuya YamashitaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-8413-5468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe previously reported that patients with cholesteryl ester transfer protein (CETP) deficiency (CETP-D) have a higher prevalence of atherosclerotic cardiovascular disease, in spite of increased HDL-C levels. However, characterization of HDL in CETP-D has not been well described. Therefore, we examined HDL particle number (PN) rather than HDL-C level. APPROACH AND

resultsNine patients with CETP-D and 9 normolipidemic subjects were enrolled. We performed gel permeation high-performance liquid chromatography (GP-HPLC) analysis, determined the cholesterol and triglyceride composition of all lipoprotein subclasses, and calculated the PN of each subclass, which consisted of 3 VLDL (large, medium, and small), 4 LDL (large, medium, small, and very small), and 5 HDL (very large, large, medium, small, and very small) subclasses. The PNs of large and medium LDL were significantly lower in CETP-D than that in healthy subjects (0.66- and 0.63-fold decrease, respectively; p<0.001), whereas the PN of very small LDL, which is known to be atherogenic, was significantly higher (1.36-fold increase, p = 0.016). The PNs of very large and large HDL in CETP-D were markedly higher than that in healthy subjects (19.9- and 4.5-fold increase, respectively; p<0.001), whereas the PNs of small and very small HDL, which have more potent anti-atherogenic functions, were significantly lower (0.76- and 0.61-fold decrease, respectively; p<0.001).

conclusionWe have assessed the PNs of detailed subclasses of patients with CETP-D for the first time. The PN of larger HDL was markedly increased, that of smaller HDL was decreased, and that of very small LDL was increased, suggesting that CETP-D has pro-atherogenic lipoprotein properties.

Indexed as

AdultCholesterol Ester Transfer ProteinsChromatography, GelChromatography, High Pressure LiquidFemaleHumansLipid Metabolism, Inborn ErrorsLipoproteinsMaleMiddle AgedCholesterol Ester Transfer ProteinsLipoproteins

Identifiers

PMID29304079
PMCPMC5755928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.